The drug, Mazdutide, is the world's first and currently only GCG/GLP-1 dual receptor agonist targeting both weight loss and ...

Researchers report that rentosertib, an AI-discovered TNIK inhibitor, showed promising safety and potential to improve lung ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Detection of cancer before a clinical diagnosis could give patients and caregivers more time for intervention and may lead to ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Specialty televisits remain common in the Veterans Health Administration following the COVID-19 pandemic, suggesting they will remain an important ongoing care modality for many patients.

IVMED-85 is a preservative-free, non-atropine daily drop that slows myopia progression by strengthening scleral and corneal ...

Hair growth serums incorporate active ingredients that encourage hair thickening. One of the most effective ingredients is ...

This Small-cap Pharma Stock, engaged in the research and development of innovative pharmaceutical products, focusing on therapies for unmet medical needs, hit a 20 percent lower circuit after the ...

At ASCO, researchers presented results of Phase I trials evaluating combinations of KRAS G12C inhibitors, EGFR inhibitors, and chemotherapy in colorectal cancer.

Positive interpretations of randomized phase 3 oncology trials often are based on improvements in unvalidated alternative ...